Ionis Pharmaceuticals Inc (IONS): Next-Year EPS Estimate 67.67%
As of 2026-06-04, Ionis Pharmaceuticals Inc (IONS) has a next-year EPS growth estimate of 67.67%.
IONS was first flagged by our screen on 2026-05-28, when analyst consensus for its next-year EPS growth was revised from 67.57% to 67.67%. Current-year growth is projected at -51.86%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 67.67%
- EPS growth this year
- -51.86%
- EPS next quarter (est)
- -$1.06
- Last price
- $75.13
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 67.67% | -51.86% | -$1.06 | $75.13 |
| 2026-06-03 | 67.67% | -51.86% | -$1.06 | $73.82 |
| 2026-06-02 | 67.67% | -51.86% | -$1.06 | $72.97 |
| 2026-06-01 | 67.67% | -51.86% | -$1.06 | $75.38 |
| 2026-05-31 | 67.67% | -51.86% | -$1.06 | $76.50 |
| 2026-05-28 | 67.67% | -51.86% | -$1.06 | $77.33 |
| 2026-05-27 | 67.57% | -51.93% | -$1.06 | $76.49 |
| 2026-05-26 | 67.57% | -51.93% | -$1.06 | $76.07 |
| 2026-05-25 | 67.57% | -51.93% | -$1.06 | $75.56 |
| 2026-05-24 | 67.57% | -51.93% | -$1.06 | $75.56 |
| 2026-05-21 | 67.57% | -51.93% | -$1.06 | $75.78 |
| 2026-05-20 | 67.57% | -51.93% | -$1.06 | $75.06 |
| 2026-05-19 | 66.44% | -51.09% | -$1.06 | $73.84 |
| 2026-05-18 | 68.17% | -50.50% | -$1.06 | $72.52 |
| 2026-05-17 | 68.17% | -50.50% | -$1.06 | $74.23 |
| 2026-05-14 | 68.94% | -48.44% | -$1.03 | $75.68 |
| 2026-05-13 | 68.94% | -48.44% | -$1.03 | $77.75 |
| 2026-05-12 | 68.94% | -48.44% | -$1.03 | $75.83 |
| 2026-05-11 | 68.94% | -48.44% | -$1.03 | $75.38 |
| 2026-05-10 | 68.94% | -48.44% | -$1.03 | $75.71 |
| 2026-05-07 | 68.94% | -48.44% | -$1.03 | $76.02 |
| 2026-05-06 | 68.94% | -48.44% | -$1.03 | $76.85 |
| 2026-05-05 | 68.94% | -48.44% | -$1.03 | $75.25 |
| 2026-05-04 | 68.94% | -48.44% | -$1.03 | $75.45 |
| 2026-05-03 | 68.94% | -48.44% | -$1.03 | $75.28 |
| 2026-04-30 | 70.13% | -46.09% | -$1.02 | $74.76 |
| 2026-04-29 | 70.50% | -64.39% | -$1.06 | $74.83 |
| 2026-04-28 | 71.48% | -69.65% | -$0.88 | $71.78 |
| 2026-04-27 | 71.48% | -69.65% | -$0.88 | $72.23 |
| 2026-04-26 | 71.48% | -69.65% | -$0.88 | $73.27 |
Recent News
- JPMorgan says large-cap biotech is back as profits and pipelines fuel upsideInvesting.com
- Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis BBusiness Wire
- Ionis Pharmaceuticals, Inc. Q1 2026 Earnings Call SummaryMoby
- Ionis Pharmaceuticals: Q1 Earnings SnapshotAssociated Press
- Ionis Pharmaceuticals: Q1 Earnings SnapshotAssociated Press
- Ionis reports first quarter 2026 financial results and highlights progress on key programsBusiness Wire
- Ionis reports first quarter 2026 financial results and highlights progress on key programsBusiness Wire
- Nike downgraded, IBM initiated: Wall Street's top analyst callsThe Fly
- Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority ReviewBusiness Wire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Ionis Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Ionis Pharmaceuticals Inc (IONS) has a next-year EPS growth estimate of 67.67%, based on analyst consensus.
When was the latest EPS estimate revision for IONS?▾
The most recent revision occurred on 2026-05-28, when analysts adjusted the next-year EPS growth estimate from 67.57% to 67.67%.
What sector and industry does Ionis Pharmaceuticals Inc belong to?▾
Ionis Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IONS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ionis Pharmaceuticals Inc (IONS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports